TB Testing Services

Description

The Trust requires the provision of an Interferon Gamma Release Assay (IGRA) testing service for the detection of Mycobacterium tuberculosis infection using the T-SPOT.TB assay, which is the Trust's established standard referred test for Tuberculosis (TB) screening and diagnosis support. Based on current activity levels, the estimated annual demand is approximately 2,820 T-SPOT.TB tests. This volume is indicative only and does not constitute a guaranteed commitment. The contract will ensure continuity of a reliable, high-quality referred testing service that delivers accurate and timely results to support patient diagnosis, treatment decisions and infection control requirements.

Key facts

Procedure

Direct award

Lots

1

Contact

uhdb.procurementhelpdesk@nhs.net

Contract period

1 Nov 2026 → 31 Oct 2027

Value incl. VAT

£159k

Category

services

Awarded suppliers

• OXFORD IMMUNOTEC LIMITED · GB-COH-04516079 · UKJ14, GB

Ground given for limiting competition

The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.

The supplier is the sole provider of the Trust's standard T-SPOT.TB testing service. Transitioning to an alternative assay would require significant clinical validation and staff training, with potential disruption to established pathways and delays to diagnosis and treatment. Maintaining the current supplier ensures continuity of service and patient care.